missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant SARS-CoV-2 K986P V987P Spike S2 His Protein, CF
2 Point Mutations.
Marca: R&D Systems™ 10639-CV-100
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
Bioassay data are not available.
Especificaciones
| YP_009724390.1 | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. | |
| M.W. (Observed): 75-95 kDa, under reducing conditions, M.W. (Theoretical): 60 kDa | |
| Human embryonic kidney cell, HEK293-derived sars-cov-2 Spike S2 Subunit protein Ser686-Lys1211 (Lys986Pro, Val987Pro), with a C-terminal 6-His tag | |
| <0.10 EU per 1 μg of the protein by the LAL method. | |
| Unconjugated | |
| >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
| Bioactivity | |
| 43740568 | |
| 100 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. | |
| COVID-19, S2 protein, SARS-CoV-2, SARS-CoV-2 Spike, Spike glycoprotein Subunit 2, spike protein, Spike protein S2, structural protein, surface glycoprotein | |
| Reconstitute at 500 μg/mL in PBS. | |
| SARS-CoV-2 Spike S2 |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
R&D Systems™ Recombinant SARS-CoV-2 K986P V987P Spike S2 His Protein, CF > 100 μg
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido